全体要約
2023年のグローバルな再生医療製品市場の規模は、数百万米ドルと評価されており、2030年までに成長が見込まれています。
市場は安定した成長を示すと予測されており、製品の差別化やコスト削減、サプライチェーンの最適化が重要な課題です。企業は研究開発に投資し、戦略的パートナーシップを結ぶ必要があります。
医療機器市場は2023年に6030億米ドルと推定され、今後6年間で年平均成長率5%で成長する見込みです。高齢化社会や慢性疾患の増加、医療支出の増加が市場を牽引しています。再生医療製品市場は、これらの要因により重要な役割を果たすと考えられています。
関連する質問
Acelity, DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori Therapeutics, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals
製品の差別化, コスト削減, サプライチェーンの最適化
概要
この研究報告は、世界の再生医療製品市場の成長可能性を強調しています。再生医療製品は、将来の市場で安定した成長を示すと期待されています。しかし、製品の差別化、コスト削減、供給チェーンの最適化は、再生医療製品の広範な採用にとって重要なポイントです。市場のプレーヤーは、研究開発に投資し、戦略的パートナーシップを築き、変化する消費者の好みに合わせた提供を行う必要があります。これにより、再生医療製品市場が提供する膨大な機会を活用できます。
私たちの研究によると、2023年における医療機器の世界市場は6030億米ドルと推定され、今後6年間で年平均成長率（CAGR）5%の成長が見込まれます。世界の医療費は世界のGDPの10%を占めており、高齢化人口の健康ニーズの増加、慢性疾患と感染症の有病率の増加、新興市場の拡大により、近年継続的に増加しています。医療機器市場は医療業界において重要な役割を果たしています。この市場は、医療サービスに対する世界的な需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、早期の疾病診断と治療に対する意識の高まりなど、いくつかの要因によって推進されています。
主な特徴：
再生医療製品市場に関する報告書は、さまざまな側面を反映し、業界にとって貴重な洞察を提供します。
市場規模と成長：この調査報告書は、再生医療製品市場の現在の規模と成長に関する概要を提供します。歴史的データや、タイプ（例：細胞療法、組織工学）による市場のセグメンテーション、地域の内訳を含む場合があります。
市場の推進要因と課題：このレポートでは、政府の規制、環境問題、技術革新、消費者の嗜好の変化など、再生医療製品市場の成長を促進する要因を特定し分析することができます。また、インフラの制約、レンジアナイティ、初期コストの高さなど、業界が直面している課題も明らかにすることができます。
競争環境：この研究報告書は再生医療製品市場の競争環境の分析を提供します。主要プレーヤーのプロフィール、市場シェア、戦略、製品の提供が含まれています。また、新興プレーヤーとその市場への潜在的な影響も強調されることがあります。
技術の進展：この調査報告書では、再生医療製品業界における最新の技術の進展について詳しく説明することができます。これには、再生医療製品技術の進歩、再生医療製品の新規参入者、再生医療製品への新規投資、そして再生医療製品の未来を形作るその他の革新が含まれます。
ダウンストリーム傾向: このレポートは、再生医療製品市場における顧客の傾向や採用トレンドについての洞察を提供することができます。顧客の購買意思決定に影響を与える要因や、再生医療製品の好みに関する情報を含んでいます。
政府の政策とインセンティブ：この調査報告書は、再生医療製品市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制フレームワーク、補助金、税制上のインセンティブ、再生医療製品市場を促進するためのその他の措置の評価が含まれる場合があります。また、報告書は、市場成長を促進する上でこれらの政策の効果も評価しています。
環境影響と持続可能性：この研究報告書では、再生医療製品市場の環境影響と持続可能性の側面を評価しています。
市場予測と将来の展望：実施された分析に基づいて、リサーチレポートは再生医療製品業界の市場予測と展望を提供します。これには、市場規模の予測、成長率、地域の動向、技術の進展や政策の展開に関する予測が含まれます。
推奨事項と機会：この報告書は、業界の利害関係者、政策立案者、投資家への推奨事項で締めくくられています。新たなトレンドを活用し、課題を克服し、再生医療製品市場の成長と発展に貢献する機会について強調しています。
市場セグメンテーション
再生医療製品市場は、タイプとアプリケーションによって分かれています。2019年から2030年の期間において、セグメント間の成長は、タイプおよびアプリケーションごとの消費価値に関する正確な計算および予測を提供します。
タイプ別のセグメンテーション
細胞療法
組織工学
バイオマテリアル
その他
アプリケーション別のセグメンテーション
皮膚科学
心血管
中枢神経系
整形外科
その他
このレポートは地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東とアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、プライマリーエキスパートから得た情報や、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した結果に基づいて選定されました。
アセリティ
デピュイ・シンセス
メドトロニック
ジンバーボイメット
ストライカー
ミメダックス・グループ
器官形成
ユニキュア
セルラーダイナミクスインターナショナル
オシリスセラピューティクス
Vcanbio
ガミダセル
ゴールデンメディテック
サイタリ・セラピューティクス
セルジーン
ベリセル社
グアンハオバイオテクノロジー
メソブラスト
幹細胞技術
ベリクム・ファーマシューティカルズ
本報告書で取り上げられた主要な質問
再生医療製品市場の10年展望は何ですか？
再生医療製品市場の成長を促進している要因は何ですか、世界的および地域別に。
市場と地域によって最も急速に成長する技術はどれですか？
再生医療製品の市場機会は、最終市場の規模によってどのように異なりますか？
再生医療製品は、タイプや用途によって分類されますか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの再生医療製品、年間売上、2019年～2030年
2.1.2 再生医療製品の世界市場の現状分析・将来予測、地理別、2019年、2023年および2030年
2.1.3 再生医療製品の世界市場の現状分析・将来予測、国・地域別、2019年、2023年および2030年
2.2 再生医療製品セグメント、タイプ別
2.2.1 細胞療法
2.2.2 組織工学
2.2.3 バイオマテリアル
2.2.4 その他
2.3 再生医療製品の売上、タイプ別
2.3.1 グローバルにおける再生医療製品の売上・市場シェア、タイプ別（2019年～2024年）
2.3.2 再生医療製品のグローバルレベニュー・市場シェア、タイプ別（2019～2024年）
2.3.3 グローバルの再生医療製品、販売価格（タイプ別）（2019年～2024年）
2.4 再生医療製品セグメント、用途別
2.4.1 皮膚科学
2.4.2 心血管系
2.4.3 中枢神経系
2.4.4 整形外科
2.4.5 その他
2.5 再生医療製品の売上、用途別
2.5.1 グローバルの再生医療製品、収益・市場シェア（用途別）（2019年～2024年）
2.5.2 再生医療製品のグローバルレベニュー・市場シェア、用途別（2019～2024年）
2.5.3 グローバルの再生医療製品、販売価格（用途別）（2019年～2024年）
3 グローバルにおける再生医療製品、企業別
3.1 グローバルにおける再生医療製品市場のブレークダウンデータ、企業別
3.1.1 グローバルにおける再生医療製品の年間売上、企業別（2019年～2024年）
3.1.2 グローバルにおける再生医療製品の売上・市場シェア、企業別（2019年～2024年）
3.2 グローバルにおける再生医療製品の年間収益、企業別（2019年～2024年）
3.2.1 グローバルにおける再生医療製品市場の収益規模、企業別（2019年～2024年）
3.2.2 グローバルにおける再生医療製品市場の収益シェア、企業別（2019年～2024年）
3.3 グローバルにおける再生医療製品の販売価格、企業別
3.4 再生医療製品の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 再生医療製品の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供している再生医療製品製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2019年～2024年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 再生医療製品の世界市場過去推移レビュー、地理別
4.1 再生医療製品の世界市場規模の過去推移、地理別（2019年～2024年）
4.1.1 グローバルにおける再生医療製品の年間売上、地理別（2019年～2024年）
4.1.2 グローバルにおける再生医療製品の年間収益、地理別（2019年～2024年）
4.2 再生医療製品の世界市場規模の過去推移、国・地域別（2019年～2024年）
4.2.1 グローバルにおける再生医療製品の年間売上、国・地域別（2019年～2024年）
4.2.2 グローバルにおける再生医療製品の年間収益、国・地域別（2019年～2024年）
4.3 アメリカズにおける再生医療製品の売上成長
4.4 APACにおける再生医療製品の売上成長
4.5 ヨーロッパにおける再生医療製品の売上成長
4.6 中東・アフリカにおける再生医療製品の売上成長
5 アメリカズ
5.1 アメリカズにおける再生医療製品の売上、国別
5.1.1 アメリカズにおける再生医療製品の売上規模、国別（2019年～2024年）
5.1.2 アメリカズにおける再生医療製品市場の収益規模、国別（2019年～2024年）
5.2 アメリカズにおける再生医療製品の売上、タイプ別
5.3 アメリカズにおける再生医療製品の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける再生医療製品の売上、地域別
6.1.1 APACにおける再生医療製品の売上規模、地域別（2019年～2024年）
6.1.2 APACにおける再生医療製品市場の収益規模、地域別（2019年～2024年）
6.2 APACにおける再生医療製品の売上、タイプ別
6.3 APACにおける再生医療製品の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおける再生医療製品、国別
7.1.1 ヨーロッパにおける再生医療製品の売上規模、国別（2019年～2024年）
7.1.2 ヨーロッパにおける再生医療製品市場の収益規模、国別（2019年～2024年）
7.2 ヨーロッパにおける再生医療製品の売上、タイプ別
7.3 ヨーロッパにおける再生医療製品の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおける再生医療製品、国別
8.1.1 中東・アフリカにおける再生医療製品の売上規模、国別（2019年～2024年）
8.1.2 中東・アフリカにおける再生医療製品市場の収益規模、国別（2019年～2024年）
8.2 中東・アフリカにおける再生医療製品の売上、タイプ別
8.3 中東・アフリカにおける再生医療製品の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 再生医療製品の製造コスト構造分析
10.3 再生医療製品の製造プロセス分析
10.4 再生医療製品のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 再生医療製品の流通業者
11.3 再生医療製品の顧客
12 再生医療製品の世界市場予測レビュー、地理別
12.1 グローバルにおける再生医療製品の市場規模予測、地域別
12.1.1 グローバルの再生医療製品、市場予測（地域別）（2025年～2030年）
12.1.2 グローバルの再生医療製品、年間収益予測（地域別）（2025年～2030年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおける再生医療製品の市場予測、タイプ別
12.7 グローバルにおける再生医療製品の市場予測、用途別
13 キープレイヤー分析
13.1 Acelity
13.1.1 Acelity：企業情報
13.1.2 Acelity：再生医療製品製品ポートフォリオと特徴
13.1.3 Acelity：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.1.4 Acelity：主要事業概要
13.1.5 Acelity：直近の展開
13.2 DePuy Synthes
13.2.1 DePuy Synthes：企業情報
13.2.2 DePuy Synthes：再生医療製品製品ポートフォリオと特徴
13.2.3 DePuy Synthes：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.2.4 DePuy Synthes：主要事業概要
13.2.5 DePuy Synthes：直近の展開
13.3 Medtronic
13.3.1 Medtronic：企業情報
13.3.2 Medtronic：再生医療製品製品ポートフォリオと特徴
13.3.3 Medtronic：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.3.4 Medtronic：主要事業概要
13.3.5 Medtronic：直近の展開
13.4 ZimmerBiomet
13.4.1 ZimmerBiomet：企業情報
13.4.2 ZimmerBiomet：再生医療製品製品ポートフォリオと特徴
13.4.3 ZimmerBiomet：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.4.4 ZimmerBiomet：主要事業概要
13.4.5 ZimmerBiomet：直近の展開
13.5 Stryker
13.5.1 Stryker：企業情報
13.5.2 Stryker：再生医療製品製品ポートフォリオと特徴
13.5.3 Stryker：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.5.4 Stryker：主要事業概要
13.5.5 Stryker：直近の展開
13.6 MiMedx Group
13.6.1 MiMedx Group：企業情報
13.6.2 MiMedx Group：再生医療製品製品ポートフォリオと特徴
13.6.3 MiMedx Group：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.6.4 MiMedx Group：主要事業概要
13.6.5 MiMedx Group：直近の展開
13.7 Organogenesis
13.7.1 Organogenesis：企業情報
13.7.2 Organogenesis：再生医療製品製品ポートフォリオと特徴
13.7.3 Organogenesis：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.7.4 Organogenesis：主要事業概要
13.7.5 Organogenesis：直近の展開
13.8 UniQure
13.8.1 UniQure：企業情報
13.8.2 UniQure：再生医療製品製品ポートフォリオと特徴
13.8.3 UniQure：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.8.4 UniQure：主要事業概要
13.8.5 UniQure：直近の展開
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International：企業情報
13.9.2 Cellular Dynamics International：再生医療製品製品ポートフォリオと特徴
13.9.3 Cellular Dynamics International：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.9.4 Cellular Dynamics International：主要事業概要
13.9.5 Cellular Dynamics International：直近の展開
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics：企業情報
13.10.2 Osiris Therapeutics：再生医療製品製品ポートフォリオと特徴
13.10.3 Osiris Therapeutics：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.10.4 Osiris Therapeutics：主要事業概要
13.10.5 Osiris Therapeutics：直近の展開
13.11 Vcanbio
13.11.1 Vcanbio：企業情報
13.11.2 Vcanbio：再生医療製品製品ポートフォリオと特徴
13.11.3 Vcanbio：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.11.4 Vcanbio：主要事業概要
13.11.5 Vcanbio：直近の展開
13.12 Gamida Cell
13.12.1 Gamida Cell：企業情報
13.12.2 Gamida Cell：再生医療製品製品ポートフォリオと特徴
13.12.3 Gamida Cell：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.12.4 Gamida Cell：主要事業概要
13.12.5 Gamida Cell：直近の展開
13.13 Golden Meditech
13.13.1 Golden Meditech：企業情報
13.13.2 Golden Meditech：再生医療製品製品ポートフォリオと特徴
13.13.3 Golden Meditech：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.13.4 Golden Meditech：主要事業概要
13.13.5 Golden Meditech：直近の展開
13.14 Cytori Therapeutics
13.14.1 Cytori Therapeutics：企業情報
13.14.2 Cytori Therapeutics：再生医療製品製品ポートフォリオと特徴
13.14.3 Cytori Therapeutics：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.14.4 Cytori Therapeutics：主要事業概要
13.14.5 Cytori Therapeutics：直近の展開
13.15 Celgene
13.15.1 Celgene：企業情報
13.15.2 Celgene：再生医療製品製品ポートフォリオと特徴
13.15.3 Celgene：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.15.4 Celgene：主要事業概要
13.15.5 Celgene：直近の展開
13.16 Vericel Corporation
13.16.1 Vericel Corporation：企業情報
13.16.2 Vericel Corporation：再生医療製品製品ポートフォリオと特徴
13.16.3 Vericel Corporation：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.16.4 Vericel Corporation：主要事業概要
13.16.5 Vericel Corporation：直近の展開
13.17 Guanhao Biotech
13.17.1 Guanhao Biotech：企業情報
13.17.2 Guanhao Biotech：再生医療製品製品ポートフォリオと特徴
13.17.3 Guanhao Biotech：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.17.4 Guanhao Biotech：主要事業概要
13.17.5 Guanhao Biotech：直近の展開
13.18 Mesoblast
13.18.1 Mesoblast：企業情報
13.18.2 Mesoblast：再生医療製品製品ポートフォリオと特徴
13.18.3 Mesoblast：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.18.4 Mesoblast：主要事業概要
13.18.5 Mesoblast：直近の展開
13.19 Stemcell Technologes
13.19.1 Stemcell Technologes：企業情報
13.19.2 Stemcell Technologes：再生医療製品製品ポートフォリオと特徴
13.19.3 Stemcell Technologes：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.19.4 Stemcell Technologes：主要事業概要
13.19.5 Stemcell Technologes：直近の展開
13.20 Bellicum Pharmaceuticals
13.20.1 Bellicum Pharmaceuticals：企業情報
13.20.2 Bellicum Pharmaceuticals：再生医療製品製品ポートフォリオと特徴
13.20.3 Bellicum Pharmaceuticals：再生医療製品売上・収益・価格およびグロスマージン（2019年～2024年）
13.20.4 Bellicum Pharmaceuticals：主要事業概要
13.20.5 Bellicum Pharmaceuticals：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The research report highlights the growth potential of the global Regenerative Medicine Products market. Regenerative Medicine Products are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Regenerative Medicine Products. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Regenerative Medicine Products market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Regenerative Medicine Products market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Regenerative Medicine Products market. It may include historical data, market segmentation by Type (e.g., Cell Therapy, Tissue Engineering), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Regenerative Medicine Products market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Regenerative Medicine Products market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Regenerative Medicine Products industry. This include advancements in Regenerative Medicine Products technology, Regenerative Medicine Products new entrants, Regenerative Medicine Products new investment, and other innovations that are shaping the future of Regenerative Medicine Products.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Regenerative Medicine Products market. It includes factors influencing customer ' purchasing decisions, preferences for Regenerative Medicine Products product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Regenerative Medicine Products market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Regenerative Medicine Products market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Regenerative Medicine Products market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Regenerative Medicine Products industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Regenerative Medicine Products market.
Market Segmentation:
Regenerative Medicine Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Cell Therapy
Tissue Engineering
Biomaterial
Others
Segmentation by application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Acelity
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori Therapeutics
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologes
Bellicum Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Regenerative Medicine Products market?
What factors are driving Regenerative Medicine Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Regenerative Medicine Products market opportunities vary by end market size?
How does Regenerative Medicine Products break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Regenerative Medicine Products Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Regenerative Medicine Products by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Regenerative Medicine Products by Country/Region, 2019, 2023 & 2030
2.2 Regenerative Medicine Products Segment by Type
2.2.1 Cell Therapy
2.2.2 Tissue Engineering
2.2.3 Biomaterial
2.2.4 Others
2.3 Regenerative Medicine Products Sales by Type
2.3.1 Global Regenerative Medicine Products Sales Market Share by Type (2019-2024)
2.3.2 Global Regenerative Medicine Products Revenue and Market Share by Type (2019-2024)
2.3.3 Global Regenerative Medicine Products Sale Price by Type (2019-2024)
2.4 Regenerative Medicine Products Segment by Application
2.4.1 Dermatology
2.4.2 Cardiovascular
2.4.3 CNS
2.4.4 Orthopedic
2.4.5 Others
2.5 Regenerative Medicine Products Sales by Application
2.5.1 Global Regenerative Medicine Products Sale Market Share by Application (2019-2024)
2.5.2 Global Regenerative Medicine Products Revenue and Market Share by Application (2019-2024)
2.5.3 Global Regenerative Medicine Products Sale Price by Application (2019-2024)
3 Global Regenerative Medicine Products by Company
3.1 Global Regenerative Medicine Products Breakdown Data by Company
3.1.1 Global Regenerative Medicine Products Annual Sales by Company (2019-2024)
3.1.2 Global Regenerative Medicine Products Sales Market Share by Company (2019-2024)
3.2 Global Regenerative Medicine Products Annual Revenue by Company (2019-2024)
3.2.1 Global Regenerative Medicine Products Revenue by Company (2019-2024)
3.2.2 Global Regenerative Medicine Products Revenue Market Share by Company (2019-2024)
3.3 Global Regenerative Medicine Products Sale Price by Company
3.4 Key Manufacturers Regenerative Medicine Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Regenerative Medicine Products Product Location Distribution
3.4.2 Players Regenerative Medicine Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Regenerative Medicine Products by Geographic Region
4.1 World Historic Regenerative Medicine Products Market Size by Geographic Region (2019-2024)
4.1.1 Global Regenerative Medicine Products Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Regenerative Medicine Products Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Regenerative Medicine Products Market Size by Country/Region (2019-2024)
4.2.1 Global Regenerative Medicine Products Annual Sales by Country/Region (2019-2024)
4.2.2 Global Regenerative Medicine Products Annual Revenue by Country/Region (2019-2024)
4.3 Americas Regenerative Medicine Products Sales Growth
4.4 APAC Regenerative Medicine Products Sales Growth
4.5 Europe Regenerative Medicine Products Sales Growth
4.6 Middle East & Africa Regenerative Medicine Products Sales Growth
5 Americas
5.1 Americas Regenerative Medicine Products Sales by Country
5.1.1 Americas Regenerative Medicine Products Sales by Country (2019-2024)
5.1.2 Americas Regenerative Medicine Products Revenue by Country (2019-2024)
5.2 Americas Regenerative Medicine Products Sales by Type
5.3 Americas Regenerative Medicine Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Regenerative Medicine Products Sales by Region
6.1.1 APAC Regenerative Medicine Products Sales by Region (2019-2024)
6.1.2 APAC Regenerative Medicine Products Revenue by Region (2019-2024)
6.2 APAC Regenerative Medicine Products Sales by Type
6.3 APAC Regenerative Medicine Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Regenerative Medicine Products by Country
7.1.1 Europe Regenerative Medicine Products Sales by Country (2019-2024)
7.1.2 Europe Regenerative Medicine Products Revenue by Country (2019-2024)
7.2 Europe Regenerative Medicine Products Sales by Type
7.3 Europe Regenerative Medicine Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Regenerative Medicine Products by Country
8.1.1 Middle East & Africa Regenerative Medicine Products Sales by Country (2019-2024)
8.1.2 Middle East & Africa Regenerative Medicine Products Revenue by Country (2019-2024)
8.2 Middle East & Africa Regenerative Medicine Products Sales by Type
8.3 Middle East & Africa Regenerative Medicine Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Regenerative Medicine Products
10.3 Manufacturing Process Analysis of Regenerative Medicine Products
10.4 Industry Chain Structure of Regenerative Medicine Products
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Regenerative Medicine Products Distributors
11.3 Regenerative Medicine Products Customer
12 World Forecast Review for Regenerative Medicine Products by Geographic Region
12.1 Global Regenerative Medicine Products Market Size Forecast by Region
12.1.1 Global Regenerative Medicine Products Forecast by Region (2025-2030)
12.1.2 Global Regenerative Medicine Products Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Regenerative Medicine Products Forecast by Type
12.7 Global Regenerative Medicine Products Forecast by Application
13 Key Players Analysis
13.1 Acelity
13.1.1 Acelity Company Information
13.1.2 Acelity Regenerative Medicine Products Product Portfolios and Specifications
13.1.3 Acelity Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Acelity Main Business Overview
13.1.5 Acelity Latest Developments
13.2 DePuy Synthes
13.2.1 DePuy Synthes Company Information
13.2.2 DePuy Synthes Regenerative Medicine Products Product Portfolios and Specifications
13.2.3 DePuy Synthes Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 DePuy Synthes Main Business Overview
13.2.5 DePuy Synthes Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Regenerative Medicine Products Product Portfolios and Specifications
13.3.3 Medtronic Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 ZimmerBiomet
13.4.1 ZimmerBiomet Company Information
13.4.2 ZimmerBiomet Regenerative Medicine Products Product Portfolios and Specifications
13.4.3 ZimmerBiomet Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 ZimmerBiomet Main Business Overview
13.4.5 ZimmerBiomet Latest Developments
13.5 Stryker
13.5.1 Stryker Company Information
13.5.2 Stryker Regenerative Medicine Products Product Portfolios and Specifications
13.5.3 Stryker Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Stryker Main Business Overview
13.5.5 Stryker Latest Developments
13.6 MiMedx Group
13.6.1 MiMedx Group Company Information
13.6.2 MiMedx Group Regenerative Medicine Products Product Portfolios and Specifications
13.6.3 MiMedx Group Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MiMedx Group Main Business Overview
13.6.5 MiMedx Group Latest Developments
13.7 Organogenesis
13.7.1 Organogenesis Company Information
13.7.2 Organogenesis Regenerative Medicine Products Product Portfolios and Specifications
13.7.3 Organogenesis Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Organogenesis Main Business Overview
13.7.5 Organogenesis Latest Developments
13.8 UniQure
13.8.1 UniQure Company Information
13.8.2 UniQure Regenerative Medicine Products Product Portfolios and Specifications
13.8.3 UniQure Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 UniQure Main Business Overview
13.8.5 UniQure Latest Developments
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International Company Information
13.9.2 Cellular Dynamics International Regenerative Medicine Products Product Portfolios and Specifications
13.9.3 Cellular Dynamics International Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cellular Dynamics International Main Business Overview
13.9.5 Cellular Dynamics International Latest Developments
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics Company Information
13.10.2 Osiris Therapeutics Regenerative Medicine Products Product Portfolios and Specifications
13.10.3 Osiris Therapeutics Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Osiris Therapeutics Main Business Overview
13.10.5 Osiris Therapeutics Latest Developments
13.11 Vcanbio
13.11.1 Vcanbio Company Information
13.11.2 Vcanbio Regenerative Medicine Products Product Portfolios and Specifications
13.11.3 Vcanbio Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Vcanbio Main Business Overview
13.11.5 Vcanbio Latest Developments
13.12 Gamida Cell
13.12.1 Gamida Cell Company Information
13.12.2 Gamida Cell Regenerative Medicine Products Product Portfolios and Specifications
13.12.3 Gamida Cell Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Gamida Cell Main Business Overview
13.12.5 Gamida Cell Latest Developments
13.13 Golden Meditech
13.13.1 Golden Meditech Company Information
13.13.2 Golden Meditech Regenerative Medicine Products Product Portfolios and Specifications
13.13.3 Golden Meditech Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Golden Meditech Main Business Overview
13.13.5 Golden Meditech Latest Developments
13.14 Cytori Therapeutics
13.14.1 Cytori Therapeutics Company Information
13.14.2 Cytori Therapeutics Regenerative Medicine Products Product Portfolios and Specifications
13.14.3 Cytori Therapeutics Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Cytori Therapeutics Main Business Overview
13.14.5 Cytori Therapeutics Latest Developments
13.15 Celgene
13.15.1 Celgene Company Information
13.15.2 Celgene Regenerative Medicine Products Product Portfolios and Specifications
13.15.3 Celgene Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Celgene Main Business Overview
13.15.5 Celgene Latest Developments
13.16 Vericel Corporation
13.16.1 Vericel Corporation Company Information
13.16.2 Vericel Corporation Regenerative Medicine Products Product Portfolios and Specifications
13.16.3 Vericel Corporation Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Vericel Corporation Main Business Overview
13.16.5 Vericel Corporation Latest Developments
13.17 Guanhao Biotech
13.17.1 Guanhao Biotech Company Information
13.17.2 Guanhao Biotech Regenerative Medicine Products Product Portfolios and Specifications
13.17.3 Guanhao Biotech Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Guanhao Biotech Main Business Overview
13.17.5 Guanhao Biotech Latest Developments
13.18 Mesoblast
13.18.1 Mesoblast Company Information
13.18.2 Mesoblast Regenerative Medicine Products Product Portfolios and Specifications
13.18.3 Mesoblast Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Mesoblast Main Business Overview
13.18.5 Mesoblast Latest Developments
13.19 Stemcell Technologes
13.19.1 Stemcell Technologes Company Information
13.19.2 Stemcell Technologes Regenerative Medicine Products Product Portfolios and Specifications
13.19.3 Stemcell Technologes Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Stemcell Technologes Main Business Overview
13.19.5 Stemcell Technologes Latest Developments
13.20 Bellicum Pharmaceuticals
13.20.1 Bellicum Pharmaceuticals Company Information
13.20.2 Bellicum Pharmaceuticals Regenerative Medicine Products Product Portfolios and Specifications
13.20.3 Bellicum Pharmaceuticals Regenerative Medicine Products Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Bellicum Pharmaceuticals Main Business Overview
13.20.5 Bellicum Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Regenerative Medicine Products Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Regenerative Medicine Products Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Cell Therapy Table 4. Major Players of Tissue Engineering Table 5. Major Players of Biomaterial Table 6. Major Players of Others Table 7. Global Regenerative Medicine Products Sales by Type (2019-2024) & (Units) Table 8. Global Regenerative Medicine Products Sales Market Share by Type (2019-2024) Table 9. Global Regenerative Medicine Products Revenue by Type (2019-2024) & ($ million) Table 10. Global Regenerative Medicine Products Revenue Market Share by Type (2019-2024) Table 11. Global Regenerative Medicine Products Sale Price by Type (2019-2024) & (USD/Unit) Table 12. Global Regenerative Medicine Products Sales by Application (2019-2024) & (Units) Table 13. Global Regenerative Medicine Products Sales Market Share by Application (2019-2024) Table 14. Global Regenerative Medicine Products Revenue by Application (2019-2024) Table 15. Global Regenerative Medicine Products Revenue Market Share by Application (2019-2024) Table 16. Global Regenerative Medicine Products Sale Price by Application (2019-2024) & (USD/Unit) Table 17. Global Regenerative Medicine Products Sales by Company (2019-2024) & (Units) Table 18. Global Regenerative Medicine Products Sales Market Share by Company (2019-2024) Table 19. Global Regenerative Medicine Products Revenue by Company (2019-2024) ($ Millions) Table 20. Global Regenerative Medicine Products Revenue Market Share by Company (2019-2024) Table 21. Global Regenerative Medicine Products Sale Price by Company (2019-2024) & (USD/Unit) Table 22. Key Manufacturers Regenerative Medicine Products Producing Area Distribution and Sales Area Table 23. Players Regenerative Medicine Products Products Offered Table 24. Regenerative Medicine Products Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Regenerative Medicine Products Sales by Geographic Region (2019-2024) & (Units) Table 28. Global Regenerative Medicine Products Sales Market Share Geographic Region (2019-2024) Table 29. Global Regenerative Medicine Products Revenue by Geographic Region (2019-2024) & ($ millions) Table 30. Global Regenerative Medicine Products Revenue Market Share by Geographic Region (2019-2024) Table 31. Global Regenerative Medicine Products Sales by Country/Region (2019-2024) & (Units) Table 32. Global Regenerative Medicine Products Sales Market Share by Country/Region (2019-2024) Table 33. Global Regenerative Medicine Products Revenue by Country/Region (2019-2024) & ($ millions) Table 34. Global Regenerative Medicine Products Revenue Market Share by Country/Region (2019-2024) Table 35. Americas Regenerative Medicine Products Sales by Country (2019-2024) & (Units) Table 36. Americas Regenerative Medicine Products Sales Market Share by Country (2019-2024) Table 37. Americas Regenerative Medicine Products Revenue by Country (2019-2024) & ($ Millions) Table 38. Americas Regenerative Medicine Products Revenue Market Share by Country (2019-2024) Table 39. Americas Regenerative Medicine Products Sales by Type (2019-2024) & (Units) Table 40. Americas Regenerative Medicine Products Sales by Application (2019-2024) & (Units) Table 41. APAC Regenerative Medicine Products Sales by Region (2019-2024) & (Units) Table 42. APAC Regenerative Medicine Products Sales Market Share by Region (2019-2024) Table 43. APAC Regenerative Medicine Products Revenue by Region (2019-2024) & ($ Millions) Table 44. APAC Regenerative Medicine Products Revenue Market Share by Region (2019-2024) Table 45. APAC Regenerative Medicine Products Sales by Type (2019-2024) & (Units) Table 46. APAC Regenerative Medicine Products Sales by Application (2019-2024) & (Units) Table 47. Europe Regenerative Medicine Products Sales by Country (2019-2024) & (Units) Table 48. Europe Regenerative Medicine Products Sales Market Share by Country (2019-2024) Table 49. Europe Regenerative Medicine Products Revenue by Country (2019-2024) & ($ Millions) Table 50. Europe Regenerative Medicine Products Revenue Market Share by Country (2019-2024) Table 51. Europe Regenerative Medicine Products Sales by Type (2019-2024) & (Units) Table 52. Europe Regenerative Medicine Products Sales by Application (2019-2024) & (Units) Table 53. Middle East & Africa Regenerative Medicine Products Sales by Country (2019-2024) & (Units) Table 54. Middle East & Africa Regenerative Medicine Products Sales Market Share by Country (2019-2024) Table 55. Middle East & Africa Regenerative Medicine Products Revenue by Country (2019-2024) & ($ Millions) Table 56. Middle East & Africa Regenerative Medicine Products Revenue Market Share by Country (2019-2024) Table 57. Middle East & Africa Regenerative Medicine Products Sales by Type (2019-2024) & (Units) Table 58. Middle East & Africa Regenerative Medicine Products Sales by Application (2019-2024) & (Units) Table 59. Key Market Drivers & Growth Opportunities of Regenerative Medicine Products Table 60. Key Market Challenges & Risks of Regenerative Medicine Products Table 61. Key Industry Trends of Regenerative Medicine Products Table 62. Regenerative Medicine Products Raw Material Table 63. Key Suppliers of Raw Materials Table 64. Regenerative Medicine Products Distributors List Table 65. Regenerative Medicine Products Customer List Table 66. Global Regenerative Medicine Products Sales Forecast by Region (2025-2030) & (Units) Table 67. Global Regenerative Medicine Products Revenue Forecast by Region (2025-2030) & ($ millions) Table 68. Americas Regenerative Medicine Products Sales Forecast by Country (2025-2030) & (Units) Table 69. Americas Regenerative Medicine Products Revenue Forecast by Country (2025-2030) & ($ millions) Table 70. APAC Regenerative Medicine Products Sales Forecast by Region (2025-2030) & (Units) Table 71. APAC Regenerative Medicine Products Revenue Forecast by Region (2025-2030) & ($ millions) Table 72. Europe Regenerative Medicine Products Sales Forecast by Country (2025-2030) & (Units) Table 73. Europe Regenerative Medicine Products Revenue Forecast by Country (2025-2030) & ($ millions) Table 74. Middle East & Africa Regenerative Medicine Products Sales Forecast by Country (2025-2030) & (Units) Table 75. Middle East & Africa Regenerative Medicine Products Revenue Forecast by Country (2025-2030) & ($ millions) Table 76. Global Regenerative Medicine Products Sales Forecast by Type (2025-2030) & (Units) Table 77. Global Regenerative Medicine Products Revenue Forecast by Type (2025-2030) & ($ Millions) Table 78. Global Regenerative Medicine Products Sales Forecast by Application (2025-2030) & (Units) Table 79. Global Regenerative Medicine Products Revenue Forecast by Application (2025-2030) & ($ Millions) Table 80. Acelity Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 81. Acelity Regenerative Medicine Products Product Portfolios and Specifications Table 82. Acelity Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 83. Acelity Main Business Table 84. Acelity Latest Developments Table 85. DePuy Synthes Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 86. DePuy Synthes Regenerative Medicine Products Product Portfolios and Specifications Table 87. DePuy Synthes Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 88. DePuy Synthes Main Business Table 89. DePuy Synthes Latest Developments Table 90. Medtronic Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 91. Medtronic Regenerative Medicine Products Product Portfolios and Specifications Table 92. Medtronic Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 93. Medtronic Main Business Table 94. Medtronic Latest Developments Table 95. ZimmerBiomet Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 96. ZimmerBiomet Regenerative Medicine Products Product Portfolios and Specifications Table 97. ZimmerBiomet Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 98. ZimmerBiomet Main Business Table 99. ZimmerBiomet Latest Developments Table 100. Stryker Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 101. Stryker Regenerative Medicine Products Product Portfolios and Specifications Table 102. Stryker Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 103. Stryker Main Business Table 104. Stryker Latest Developments Table 105. MiMedx Group Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 106. MiMedx Group Regenerative Medicine Products Product Portfolios and Specifications Table 107. MiMedx Group Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 108. MiMedx Group Main Business Table 109. MiMedx Group Latest Developments Table 110. Organogenesis Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 111. Organogenesis Regenerative Medicine Products Product Portfolios and Specifications Table 112. Organogenesis Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 113. Organogenesis Main Business Table 114. Organogenesis Latest Developments Table 115. UniQure Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 116. UniQure Regenerative Medicine Products Product Portfolios and Specifications Table 117. UniQure Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 118. UniQure Main Business Table 119. UniQure Latest Developments Table 120. Cellular Dynamics International Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 121. Cellular Dynamics International Regenerative Medicine Products Product Portfolios and Specifications Table 122. Cellular Dynamics International Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 123. Cellular Dynamics International Main Business Table 124. Cellular Dynamics International Latest Developments Table 125. Osiris Therapeutics Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 126. Osiris Therapeutics Regenerative Medicine Products Product Portfolios and Specifications Table 127. Osiris Therapeutics Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 128. Osiris Therapeutics Main Business Table 129. Osiris Therapeutics Latest Developments Table 130. Vcanbio Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 131. Vcanbio Regenerative Medicine Products Product Portfolios and Specifications Table 132. Vcanbio Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 133. Vcanbio Main Business Table 134. Vcanbio Latest Developments Table 135. Gamida Cell Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 136. Gamida Cell Regenerative Medicine Products Product Portfolios and Specifications Table 137. Gamida Cell Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 138. Gamida Cell Main Business Table 139. Gamida Cell Latest Developments Table 140. Golden Meditech Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 141. Golden Meditech Regenerative Medicine Products Product Portfolios and Specifications Table 142. Golden Meditech Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 143. Golden Meditech Main Business Table 144. Golden Meditech Latest Developments Table 145. Cytori Therapeutics Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 146. Cytori Therapeutics Regenerative Medicine Products Product Portfolios and Specifications Table 147. Cytori Therapeutics Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 148. Cytori Therapeutics Main Business Table 149. Cytori Therapeutics Latest Developments Table 150. Celgene Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 151. Celgene Regenerative Medicine Products Product Portfolios and Specifications Table 152. Celgene Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 153. Celgene Main Business Table 154. Celgene Latest Developments Table 155. Vericel Corporation Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 156. Vericel Corporation Regenerative Medicine Products Product Portfolios and Specifications Table 157. Vericel Corporation Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 158. Vericel Corporation Main Business Table 159. Vericel Corporation Latest Developments Table 160. Guanhao Biotech Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 161. Guanhao Biotech Regenerative Medicine Products Product Portfolios and Specifications Table 162. Guanhao Biotech Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 163. Guanhao Biotech Main Business Table 164. Guanhao Biotech Latest Developments Table 165. Mesoblast Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 166. Mesoblast Regenerative Medicine Products Product Portfolios and Specifications Table 167. Mesoblast Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 168. Mesoblast Main Business Table 169. Mesoblast Latest Developments Table 170. Stemcell Technologes Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 171. Stemcell Technologes Regenerative Medicine Products Product Portfolios and Specifications Table 172. Stemcell Technologes Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 173. Stemcell Technologes Main Business Table 174. Stemcell Technologes Latest Developments Table 175. Bellicum Pharmaceuticals Basic Information, Regenerative Medicine Products Manufacturing Base, Sales Area and Its Competitors Table 176. Bellicum Pharmaceuticals Regenerative Medicine Products Product Portfolios and Specifications Table 177. Bellicum Pharmaceuticals Regenerative Medicine Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024) Table 178. Bellicum Pharmaceuticals Main Business Table 179. Bellicum Pharmaceuticals Latest Developments List of Figures Figure 1. Picture of Regenerative Medicine Products Figure 2. Regenerative Medicine Products Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Regenerative Medicine Products Sales Growth Rate 2019-2030 (Units) Figure 7. Global Regenerative Medicine Products Revenue Growth Rate 2019-2030 ($ Millions) Figure 8. Regenerative Medicine Products Sales by Region (2019, 2023 & 2030) & ($ Millions) Figure 9. Product Picture of Cell Therapy Figure 10. Product Picture of Tissue Engineering Figure 11. Product Picture of Biomaterial Figure 12. Product Picture of Others Figure 13. Global Regenerative Medicine Products Sales Market Share by Type in 2023 Figure 14. Global Regenerative Medicine Products Revenue Market Share by Type (2019-2024) Figure 15. Regenerative Medicine Products Consumed in Dermatology Figure 16. Global Regenerative Medicine Products Market: Dermatology (2019-2024) & (Units) Figure 17. Regenerative Medicine Products Consumed in Cardiovascular Figure 18. Global Regenerative Medicine Products Market: Cardiovascular (2019-2024) & (Units) Figure 19. Regenerative Medicine Products Consumed in CNS Figure 20. Global Regenerative Medicine Products Market: CNS (2019-2024) & (Units) Figure 21. Regenerative Medicine Products Consumed in Orthopedic Figure 22. Global Regenerative Medicine Products Market: Orthopedic (2019-2024) & (Units) Figure 23. Regenerative Medicine Products Consumed in Others Figure 24. Global Regenerative Medicine Products Market: Others (2019-2024) & (Units) Figure 25. Global Regenerative Medicine Products Sales Market Share by Application (2023) Figure 26. Global Regenerative Medicine Products Revenue Market Share by Application in 2023 Figure 27. Regenerative Medicine Products Sales Market by Company in 2023 (Units) Figure 28. Global Regenerative Medicine Products Sales Market Share by Company in 2023 Figure 29. Regenerative Medicine Products Revenue Market by Company in 2023 ($ Million) Figure 30. Global Regenerative Medicine Products Revenue Market Share by Company in 2023 Figure 31. Global Regenerative Medicine Products Sales Market Share by Geographic Region (2019-2024) Figure 32. Global Regenerative Medicine Products Revenue Market Share by Geographic Region in 2023 Figure 33. Americas Regenerative Medicine Products Sales 2019-2024 (Units) Figure 34. Americas Regenerative Medicine Products Revenue 2019-2024 ($ Millions) Figure 35. APAC Regenerative Medicine Products Sales 2019-2024 (Units) Figure 36. APAC Regenerative Medicine Products Revenue 2019-2024 ($ Millions) Figure 37. Europe Regenerative Medicine Products Sales 2019-2024 (Units) Figure 38. Europe Regenerative Medicine Products Revenue 2019-2024 ($ Millions) Figure 39. Middle East & Africa Regenerative Medicine Products Sales 2019-2024 (Units) Figure 40. Middle East & Africa Regenerative Medicine Products Revenue 2019-2024 ($ Millions) Figure 41. Americas Regenerative Medicine Products Sales Market Share by Country in 2023 Figure 42. Americas Regenerative Medicine Products Revenue Market Share by Country in 2023 Figure 43. Americas Regenerative Medicine Products Sales Market Share by Type (2019-2024) Figure 44. Americas Regenerative Medicine Products Sales Market Share by Application (2019-2024) Figure 45. United States Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 46. Canada Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 47. Mexico Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 48. Brazil Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 49. APAC Regenerative Medicine Products Sales Market Share by Region in 2023 Figure 50. APAC Regenerative Medicine Products Revenue Market Share by Regions in 2023 Figure 51. APAC Regenerative Medicine Products Sales Market Share by Type (2019-2024) Figure 52. APAC Regenerative Medicine Products Sales Market Share by Application (2019-2024) Figure 53. China Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 54. Japan Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 55. South Korea Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 56. Southeast Asia Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 57. India Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 58. Australia Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 59. China Taiwan Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 60. Europe Regenerative Medicine Products Sales Market Share by Country in 2023 Figure 61. Europe Regenerative Medicine Products Revenue Market Share by Country in 2023 Figure 62. Europe Regenerative Medicine Products Sales Market Share by Type (2019-2024) Figure 63. Europe Regenerative Medicine Products Sales Market Share by Application (2019-2024) Figure 64. Germany Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 65. France Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 66. UK Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 67. Italy Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 68. Russia Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 69. Middle East & Africa Regenerative Medicine Products Sales Market Share by Country in 2023 Figure 70. Middle East & Africa Regenerative Medicine Products Revenue Market Share by Country in 2023 Figure 71. Middle East & Africa Regenerative Medicine Products Sales Market Share by Type (2019-2024) Figure 72. Middle East & Africa Regenerative Medicine Products Sales Market Share by Application (2019-2024) Figure 73. Egypt Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 74. South Africa Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 75. Israel Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 76. Turkey Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 77. GCC Country Regenerative Medicine Products Revenue Growth 2019-2024 ($ Millions) Figure 78. Manufacturing Cost Structure Analysis of Regenerative Medicine Products in 2023 Figure 79. Manufacturing Process Analysis of Regenerative Medicine Products Figure 80. Industry Chain Structure of Regenerative Medicine Products Figure 81. Channels of Distribution Figure 82. Global Regenerative Medicine Products Sales Market Forecast by Region (2025-2030) Figure 83. Global Regenerative Medicine Products Revenue Market Share Forecast by Region (2025-2030) Figure 84. Global Regenerative Medicine Products Sales Market Share Forecast by Type (2025-2030) Figure 85. Global Regenerative Medicine Products Revenue Market Share Forecast by Type (2025-2030) Figure 86. Global Regenerative Medicine Products Sales Market Share Forecast by Application (2025-2030) Figure 87. Global Regenerative Medicine Products Revenue Market Share Forecast by Application (2025-2030)
